GlassScriptPhysician profile
Tanele M Cook
NPI 1710634464
$824.68
in general payments reported to CMS, 2019-2025
14 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $293 · 2024: $314 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $231.86 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $197.00 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.10 | 2023-2024 | Tradjenta, Jardiance |
| Janssen Pharmaceuticals, INC | $59.72 | 2023 | Spravato |
| Astrazeneca Pharmaceuticals LP | $59.06 | 2023-2024 | Farxiga, Breztri |
| Organon LLC | $46.19 | 2022-2023 | Nexplanon |
| Abbvie INC. | $30.76 | 2024 | |
| Dexcom, INC. | $27.11 | 2023 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $23.02 | 2023 | Veozah |
| Pfizer INC. | $20.62 | 2024 | |
| Radius Health, INC. | $19.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.66 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $15.04 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanele Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.